Deletions at 14q in malignant mesothelioma detected by microsatellite marker analysis

British Journal of Cancer

Volumn 81, Issue 7, 1999, Pages 1111-1115

  Bjorkqvist A M ^a   Wolf, M ^a,b   Nordling, S ^a   Tammilehto, L ^c   Knuuttila, A ^b   Kere, J ^d   Mattson, K ^b   Knuutila, S ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Allelic imbalance; Loss of heterozygosity; Malignant mesothelioma; Microsatellite marker analysis

Indexed keywords

MICROSATELLITE DNA;

ADULT; AGED; ALLELE; ARTICLE; CARCINOGENESIS; CHROMOSOME 14Q; CHROMOSOME MARKER; CLINICAL ARTICLE; CONTROLLED STUDY; DELETION MUTANT; FEMALE; GENE NUMBER; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MALIGNANT MESOTHELIOMA; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0032712704     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690816     Document Type: Article

References (32)

1. Abujiang P, Mori TJ, Takahashi T, Tanaka F, Kasyu I, Hitomi S and Hiai H (1998) Loss of heterozygosity (LOH) at 17q and 14q in human lung cancers. Oncogene 17: 3029-3033
2. Balsara BR, Bell DW, Sonoda G, De Rienzo A, du Manoir S, Jhanwar SC and Testa JR (1999) Comparative genomic hybridization and loss of heterozygosity analyses identify a common region of deletion at 15q11.1-15 in human malignant mesothelioma. Cancer Res 59: 450-454
3. Bandera CA, Takahashi H, Behbakhi K, Liu PC, LiVolsi VA, Benjamin I, Morgan MA, King SA, Rubin SC and Boyd J (1997) Deletion mapping of two potential chromosome 14 tumor suppressor gene loci in ovarian carcinoma. Cancer Res 57: 513-515
4. Bell DW, Jhanwar SC and Testa JR (1997) Multiple regions of allelic loss from chromosome arm 6q in malignant mesothelioma. Cancer Res 57: 4057-4062
5. Bianchi AB, Mitsunaga S-I, Cheng JQ, Klein WM, Jhanwar SC, Seizinger B, Kley N, Klein-Szanto AJP and Testa JR (1995) High frequency of inactivating mutations in the neurofibromatosis type 2 gene (NF2) in primary malignant mesothelioma. Proc Natl Acad Sci USA 92: 10854-10858
6. Björkqvist A-M, Tammilehto L, Anttila S, Mattson K and Knuutila S (1997) Recurrent DNA copy number changes in 1q, 4q, 6q, 9p, 13q, 14q and 22q detected by comparative genomic hybridization in malignant mesothelioma. Br J Cancer 75: 523-527
7. Björkqvist A-M, Tammilehto L, Nordling S, Nurminen M, Anttila S, Mattson K and Knuutila S (1998) Comparison of DNA copy number changes in malignant mesothelioma, adenocarcinoma and large-cell anaplastic carcinoma of the lung. Br J Cancer 77: 260-269
8. Browne K (1986) Mesothelioma registry data. Lancet ii(8499) 167
9. Chang WY-H, Cairns P, Schoenberg MP, Polascik TJ and Sidransky D (1995) Novel suppressor loci on chromosome 14q in primary bladder cancer. Cancer Res 55: 3246-3249
10. Cheng JQ, Jhanwar SC, Klein WM, Bell DW, Lee W-C, Altomare DA, Nobori T, Olopade OI, Buckler AJ and Testa JR (1994) p16 alterations and deletion mapping of 9p21-p22 in malignant mesothelioma. Cancer Res 54: 5547-5551
11. Demple B, Herman T and Chen DS (1991) Cloning and expression of APE, the cDNA encoding the major human apurinic endonuclease: Definition of a family of DNA repair enzymes. Proc Natl Acad Sci USA 88: 11450-11454
12. Dib C, Fauré S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissette J and Weissenbach J (1996) A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 380: 152-154
13. Fung H, Kow YW, Van Houten B, Taatjes DJ, Hatahet Z, Janssen YMW, Vacek P, Faux SP and Mossman BT (1998) Asbestos increases mammalian AP-endonuclease gene expression, protein levels, and enzyme activity in mesothelial cells. Cancer Res 58: 189-194
14. Goodglick LA and Kane AB (1990) Cytotoxicity of long and short crocidolite asbestos fibers in vitro and in vivo. Cancer Res 50: 5153-5163
15. Hagemeijer A, Versnel MA, Van Drunen E, Moret M, Bouts MJ, van der Kwast TH and Hoogsteden HC (1990) Cytogenetic analysis of mesothelioma. Cancer Genet Cytogenet 47: 1-28
16. Hansen K and Mossman BT (1987) Generation of superoxide from alveolar macrophages exposed to asbestiform and nonfibrous particles. Cancer Res 47: 1681-1686
17. Harrison L, Ascione G, Menninger JC, Ward DC and Demple B (1992) Human apurinic endonuclease gene (APE): structure and genomic mapping (chromosome 14q11.2 12). Hum Molec Genet 1: 677-680
18. Herbers J, Schullerus D, Muller H, Kenck C, Chudek J, Weimer J, Bugert P and Kovacs G (1997) Significance of chromosome arm 14q loss in nonpapillary renal cell carcinomas. Genes Chromosomes Cancer 19: 29-35
19. Kallioniemi O-P, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW and Pinkel D (1994) Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10: 231-243
20. Karjalainen A, Pukkala E, Mattson K, Tammilehto L and Vainio H (1997) Trends in mesothelioma incidence and occupational mesotheliomas in Finland in 1960-1995. Scand J Work Environ Health 23: 266-270
21. Kivipensas P, Björkqvist A-M, Karhu R, Pelin K, Linnainmaa K, Tammilehto L, Mattson K, Kallioniemi O-P and Knuutila S (1996) Gains and losses of DNA sequences in malignant mesothelioma by comparative genomic hybridization. Cancer Genet Cytogenet 89: 7-13
22. Lee W-C, Balsara B, Liu Z, Jhanwar SC and Testa JR (1996) Loss of heterozygosity analysis defines a critical region in chromosome 1p22 commonly deleted in human malignant mesothelioma. Cancer Res 56: 4297-4301
23. Lu YY, Jhanwar SC, Cheng JQ and Testa JR (1994) Deletion mapping of the short arm of chromosome 3 in human malignant mesothelioma. Genes Chromosomes Cancer 9: 76-80
24. Miller SA, Dykes DD and Polesky HF (1988) A simple salting out procedure for extracting DNAs from human nucleated cells. Nucleic Acids Res 16: 1215
25. Schwerdtle RF, Winterpacht A, Störkel S, Brenner W, Hohenfellner R, Zabel B, Huber C and Decker H-J (1997) Loss of heterozygosity studies and deletion mapping identify two putative chromosome 14q tumor suppressor loci in renal oncocytomas. Cancer Res 57: 5009-5012
26. Sekido Y, Pass HI, Bader S, Mew DJY, Christman MF, Gazdar AF and Minna JD (1995) Neurofibromatosis type 2 (NF2) gene is somatically mutated in mesothelioma but not in lung cancer. Cancer Res 55: 1227-1231
27. Simon M, von Deimling A, Larson JJ, Wellenreuther R, Kaskel P, Waha A, Warnick RE, Tew JM Jr and Menon AG (1995) Allelic losses on chromosomes 14, 10, and 1 in atypical and malignant meningiomas: A genetic model of meningioma progression. Cancer Res 55: 4696-4701
28. Taguchi T, Jhanwar SC, Siegfried JM, Keller SM and Testa JR (1993) Recurrent deletions of specific chromosomal sites in 1p, 3p, 6q, and 9p in human malignant mesothelioma. Cancer Res 53: 4349-4355
29. Tiainen M, Tammilehto L, Rautonen J, Tuomi T, Mattson K and Knuutila S (1989) Chromosomal abnormalities and their correlations with asbestos exposure and survival in patients with mesothelioma. Br J Cancer 60: 618-626
30. Wagner JC, Sleggs CA and Marchand P (1960) Diffuse pleural mesotheliomas and asbestos exposure in the Northwestern Cape Province. Br J Ind Med 17: 260-271
31. Yates DH, Corrin B, Stidolph PN and Browne K (1997) Malignant mesothelioma in south east England: clinicopathological experience of 272 cases. Thorax 52: 507-512
32. Zeiger MA, Gnarra JR, Zhar B, Linehan WM and Pass HI (1994) Loss of heterozygosity on the short arm of chromosome 3 in mesothelioma cell lines and solid tumors. Genes Chromosomes Cancer 11: 15-20